Cargando…

Her2 positivity and race predict higher mastectomy rates: a SEER database analysis

Given the difference in incidence of biologic subtype of breast cancer between black and white women, and the potential disparity in type of surgery in black and white women presenting with early stage breast cancer, this study aimed to examine the odds of mastectomy compared to lumpectomy by molecu...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwartz, Theresa L., Veerapong, Jula, Hinyard, Leslie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4656267/
https://www.ncbi.nlm.nih.gov/pubmed/26636003
http://dx.doi.org/10.1186/s40064-015-1538-x
_version_ 1782402269520592896
author Schwartz, Theresa L.
Veerapong, Jula
Hinyard, Leslie
author_facet Schwartz, Theresa L.
Veerapong, Jula
Hinyard, Leslie
author_sort Schwartz, Theresa L.
collection PubMed
description Given the difference in incidence of biologic subtype of breast cancer between black and white women, and the potential disparity in type of surgery in black and white women presenting with early stage breast cancer, this study aimed to examine the odds of mastectomy compared to lumpectomy by molecular subtype in black and white women with size T1 and T2 invasive breast cancer. Using the SEER database, breast operation choice for women over the age of 15 with T1 or T2 tumors between 2010 and 2012 were examined. Tumors were categorized according to the Breast Subtype variable in the SEER database and data were stratified by tumor size and race. Bivariate comparisons and logistic regression models adjusted for age were used. In women with T1 or T2 tumors, mastectomy rates were higher in women with Her2 positive tumors than in those with Her2 negative tumors. When Her2 results are the same among comparison groups, those women with HR positive tumors were less likely to undergo a mastectomy than those with HR negative tumors. In T1 tumors, the magnitude of the association was larger for white women than women of other races. Results suggest there are differences in surgical decision making based on breast cancer subtype in women with T1 or T2 tumors and that race may play a role for size T1 tumors. The strong association between Her2 positive tumors and higher mastectomy rates warrants further investigation.
format Online
Article
Text
id pubmed-4656267
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-46562672015-12-03 Her2 positivity and race predict higher mastectomy rates: a SEER database analysis Schwartz, Theresa L. Veerapong, Jula Hinyard, Leslie Springerplus Research Given the difference in incidence of biologic subtype of breast cancer between black and white women, and the potential disparity in type of surgery in black and white women presenting with early stage breast cancer, this study aimed to examine the odds of mastectomy compared to lumpectomy by molecular subtype in black and white women with size T1 and T2 invasive breast cancer. Using the SEER database, breast operation choice for women over the age of 15 with T1 or T2 tumors between 2010 and 2012 were examined. Tumors were categorized according to the Breast Subtype variable in the SEER database and data were stratified by tumor size and race. Bivariate comparisons and logistic regression models adjusted for age were used. In women with T1 or T2 tumors, mastectomy rates were higher in women with Her2 positive tumors than in those with Her2 negative tumors. When Her2 results are the same among comparison groups, those women with HR positive tumors were less likely to undergo a mastectomy than those with HR negative tumors. In T1 tumors, the magnitude of the association was larger for white women than women of other races. Results suggest there are differences in surgical decision making based on breast cancer subtype in women with T1 or T2 tumors and that race may play a role for size T1 tumors. The strong association between Her2 positive tumors and higher mastectomy rates warrants further investigation. Springer International Publishing 2015-11-24 /pmc/articles/PMC4656267/ /pubmed/26636003 http://dx.doi.org/10.1186/s40064-015-1538-x Text en © Schwartz et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Research
Schwartz, Theresa L.
Veerapong, Jula
Hinyard, Leslie
Her2 positivity and race predict higher mastectomy rates: a SEER database analysis
title Her2 positivity and race predict higher mastectomy rates: a SEER database analysis
title_full Her2 positivity and race predict higher mastectomy rates: a SEER database analysis
title_fullStr Her2 positivity and race predict higher mastectomy rates: a SEER database analysis
title_full_unstemmed Her2 positivity and race predict higher mastectomy rates: a SEER database analysis
title_short Her2 positivity and race predict higher mastectomy rates: a SEER database analysis
title_sort her2 positivity and race predict higher mastectomy rates: a seer database analysis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4656267/
https://www.ncbi.nlm.nih.gov/pubmed/26636003
http://dx.doi.org/10.1186/s40064-015-1538-x
work_keys_str_mv AT schwartztheresal her2positivityandracepredicthighermastectomyratesaseerdatabaseanalysis
AT veerapongjula her2positivityandracepredicthighermastectomyratesaseerdatabaseanalysis
AT hinyardleslie her2positivityandracepredicthighermastectomyratesaseerdatabaseanalysis